Literature DB >> 2311647

Interleukin 2, 4 and 5 are sequentially produced in mitogen-stimulated murine spleen cell cultures.

S Cardell1, B Sander.   

Abstract

Lymphokine production was analyzed in murine spleen lymphocytes stimulated with different T cell mitogens. Using in situ hybridization, frequencies of cells and the kinetics of production of interleukin (IL) 2, 4 and 5 were analyzed. The different mitogens varied in their ability to induce the three interleukins. IL2 was most successfully induced with a high dose of the calcium ionophore A23187 combined with phorbol 12-myristate 13-acetate (PMA). Significant frequencies of cells containing IL4 or IL5 mRNA were found among cells stimulated with an anti-CD3 antibody together with PMA, or pokeweed mitogen. The combination of anti-CD3 and PMA induced relatively high frequencies of all three cytokines. The production was sequential with the highest levels of IL2 mRNA present during the first 24 h, IL4 mRNA reaching a peak on day 2 and finally IL5 peaking on day 3. When cells that had been stimulated with mitogens in vitro were restimulated, the lymphokines were produced more rapidly. The order of production was maintained with IL2 mRNA reaching a maximum already at 3 h of culture, IL4 mRNA at 8 h and IL5 mRNA at 24 h.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311647     DOI: 10.1002/eji.1830200223

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood.

Authors:  J Andersson; U Andersson
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

2.  Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation.

Authors:  A V Gett; P D Hodgkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

4.  Differential regulation by phorbol myristate acetate of IFN-gamma and IL-4 expression in anti-CD3 stimulated mouse spleen cells.

Authors:  P Monteyne; J C Renauld; J P Coutelier
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

5.  Systemic administration of interferon-gamma-expressing plasmid reduces late allergic bronchitis in a mouse model of asthma.

Authors:  T Hayashi; K Maeda; K Hasegawa; S Nakai; T Hamachi; H Iwata
Journal:  Int J Exp Pathol       Date:  2002-04       Impact factor: 1.925

Review 6.  A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation.

Authors:  E V Rothenberg; S B Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

7.  Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression.

Authors:  A Richter; M Löhning; A Radbruch
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

8.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.

Authors:  G Le Gros; S Z Ben-Sasson; R Seder; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

9.  Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10.

Authors:  Max Löhning; Andreas Hutloff; Tilmann Kallinich; Hans Werner Mages; Kerstin Bonhagen; Andreas Radbruch; Eckard Hamelmann; Richard A Kroczek
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

10.  Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen.

Authors:  M Bette; M K Schäfer; N van Rooijen; E Weihe; B Fleischer
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.